JASPER THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense
JASPER THERAPEUTICS, INC. (JSPR) reported Increase (Decrease) in Prepaid Expense of $1.36 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2023-03-08
- JASPER THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2022 was $1.36M, a 34.33% decline from fiscal 2021.
- JASPER THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2021 was $2.07M.
- JASPER THERAPEUTICS, INC. increase (decrease) in prepaid expense for fiscal 2020 was -$179.33K.
| Period end | Increase (Decrease) in Prepaid Expense 5 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|
| 2022-12-31 | $1.36M 10-K · filed 2023-03-08 | |
| 2021-12-31 | $2.07M 10-K · filed 2023-03-08 | |
| 2020-12-31 | -$179.33K 10-K/A · filed 2021-05-24 | |
| 2019-12-31 | $326.31K 10-K/A · filed 2021-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |